Orally administered dextran sulfate is absorbed in HIV-positive individuals (Q33505214)

27 July 2017

title

Orally administered dextran sulfate is absorbed in HIV-positive individuals (English)

1 reference

27 July 2017

Hiebert LM

1

1 reference

27 July 2017

Wice SM

2

1 reference

27 July 2017

Jaques LB

3

1 reference

27 July 2017

Williams KE

4

1 reference

27 July 2017

Conly JM

5

1 reference

27 July 2017

publication date

1 February 1999

1 reference

27 July 2017

published in

Translational Research

1 reference

27 July 2017

volume

133

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

161-170

1 reference

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Dextran sulfate is poorly absorbed after oral administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Selective distribution of the heparin in mammals: conspicuous presence of heparin in lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Enhancement of natural resistance of mice to Rhodococcus equi infection by Dextran Sulfate 500.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Endocytosis of hyaluronan in rat Kupffer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

The uptake of heparin by liver sinusoidal cells in normal and atherosclerotic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990009-4

10.1016/S0022-2143(99)90009-4

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference